Exiqon A/S Release: Revised Financial Outlook 2013 Due To Temporary Supply Issues

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

Exiqon A/S (NASDAQ OMX: EXQ), a leading supplier of high-value gene expression analysis products, today announced that short-term supply chain problems with a supplier will cause a delay in order shipping for the remainder of December 2013 and affect the company’s full year results.

Help employers find you! Check out all the jobs and post your resume.
MORE ON THIS TOPIC